Amarin Corp Plc (AMRN)

[ziploc_1]

A problem for Vascepa is that , in the eyes of the public, it is just another healthy supplement, much like fish oil...Oncology drugs have massive price tickets and are still in demand because patients understand that they make the difference between life and death(or at least can extend life).

Amarin needs to make clear that Vascepa makes a difference between life and death, not just CVD.

Studies of Vascepa discuss reduction of CVD in patients, but they usually don't emphasize the difference that Vascepa can make in long term survival...By now, world figures on years of survival with Vascepa, as opposed to no Vascepa, must be available.

I personally believe that Vascepa has helped me to live to the advanced age that I have attained...I think about Vascepa in terms of my mortality instead of solely dwelling on my reduction of CVD rate.